164 related articles for article (PubMed ID: 9067579)
1. Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RAR alpha-altered sublines of HL-60.
Grillier I; Umiel T; Elstner E; Collins SJ; Koeffler HP
Leukemia; 1997 Mar; 11(3):393-400. PubMed ID: 9067579
[TBL] [Abstract][Full Text] [Related]
2. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
3. A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: implications of RARalpha-mediated signals in myeloid leukemic cells.
Ueno H; Kizaki M; Matsushita H; Muto A; Yamato K; Nishihara T; Hida T; Yoshimura H; Koeffler HP; Ikeda Y
Leuk Res; 1998 Jun; 22(6):517-25. PubMed ID: 9678718
[TBL] [Abstract][Full Text] [Related]
4. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
[TBL] [Abstract][Full Text] [Related]
5. Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-alpha and retinoid X receptor-alpha RNA by HL-60 cells.
Kizaki M; Ikeda Y; Tanosaki R; Nakajima H; Morikawa M; Sakashita A; Koeffler HP
Blood; 1993 Dec; 82(12):3592-9. PubMed ID: 8260698
[TBL] [Abstract][Full Text] [Related]
6. Mutation in the ligand-binding domain of the retinoic acid receptor alpha in HL-60 leukemic cells resistant to retinoic acid and with increased sensitivity to vitamin D3 analogs.
Doré BT; Momparler RL
Leuk Res; 1996 Sep; 20(9):761-9. PubMed ID: 8947586
[TBL] [Abstract][Full Text] [Related]
7. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
8. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway.
Hsu CA; Rishi AK; Su-Li X; Gerald TM; Dawson MI; Schiffer C; Reichert U; Shroot B; Poirier GG; Fontana JA
Blood; 1997 Jun; 89(12):4470-9. PubMed ID: 9192771
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
[TBL] [Abstract][Full Text] [Related]
10. Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid.
Elstner E; Linker-Israeli M; Le J; Umiel T; Michl P; Said JW; Binderup L; Reed JC; Koeffler HP
J Clin Invest; 1997 Jan; 99(2):349-60. PubMed ID: 9006004
[TBL] [Abstract][Full Text] [Related]
11. Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells.
Mehta K; McQueen T; Neamati N; Collins S; Andreeff M
Cell Growth Differ; 1996 Feb; 7(2):179-86. PubMed ID: 8822201
[TBL] [Abstract][Full Text] [Related]
12. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest.
Yen A; Roberson MS; Varvayanis S; Lee AT
Cancer Res; 1998 Jul; 58(14):3163-72. PubMed ID: 9679985
[TBL] [Abstract][Full Text] [Related]
14. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway.
Dawson MI; Elstner E; Kizaki M; Chen DL; Pakkala S; Kerner B; Koeffler HP
Blood; 1994 Jul; 84(2):446-52. PubMed ID: 8025272
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two novel retinoic acid-resistant cell lines derived from HL-60 cells following long-term culture with all-trans-retinoic acid.
Mori J; Suzuki S; Hara M; Kaneko A; Yamashita K; Kumagai M; Sakuma T; Kakizawa T; Yamazaki M; Takeda T; Miyamoto T; Ichikawa K; Hashizume K
Jpn J Cancer Res; 1999 Jun; 90(6):660-8. PubMed ID: 10429659
[TBL] [Abstract][Full Text] [Related]
16. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of Bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells.
Agarwal N; Mehta K
Biochem Biophys Res Commun; 1997 Jan; 230(2):251-3. PubMed ID: 9016759
[TBL] [Abstract][Full Text] [Related]
18. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR.
Monczak Y; Trudel M; Lamph WW; Miller WH
Blood; 1997 Nov; 90(9):3345-55. PubMed ID: 9345016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]